Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$112.4M
+8.7% from 2023
Prescriptions
171K
$659.10 per claim
Patients
35K
7,111 prescribers
Total spending, 2024
$112.4M
$3,225.63 per patient
Medicare prescription drug plans paid $112.4M for Diclofenac Epolamine in 2024, for 170,515 prescriptions and refills to 34,839 patients (up 8.7% from 2023). The average cost per claim was $659.10.
New York had the highest Medicare cost for Diclofenac Epolamine in 2024: $92.7M for 135,536 claims, followed by California ($6.8M).
Jimmy Li, podiatry in Woodhaven, NY, had the highest Medicare cost for Diclofenac Epolamine in 2024: 4,415 claims costing $3.2M.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jimmy Li Woodhaven, NY | Podiatry | 4,415 | 1,055 | $3.2M |
| Kwangsu Kim Bayside, NY | Podiatry | 5,425 | 850 | $3.1M |
| Xiangsheng Zheng Birmingham, AL |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 7,546 | 211,512 | 44,025 | $158.3M |
| 2023 | 7,506 | 153,853 | 34,739 | $103.4M |
| 2024 | 7,111 | 170,515 | 34,839 | $112.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 2,978 |
| 386 |
| $2.2M |
| Jung L Lee Flushing, NY | General Surgery | 2,020 | 267 | $1.6M |
| Xiaoqin S Yin Flushing, NY | Family Practice | 2,300 | 341 | $1.5M |
| Ding C Yang Staten Island, NY | Podiatry | 2,310 | 1,296 | $1.5M |
| Gary G Chen Brooklyn, NY | Internal Medicine | 1,845 | 225 | $1.5M |
| York Sing Chan Brooklyn, NY | Internal Medicine | 1,245 | 209 | $1.2M |
| Xian Min Li Brooklyn, NY | Internal Medicine | 906 | 256 | $1.2M |
| Fufu He Brooklyn, NY | Family Practice | 1,275 | 260 | $1.1M |
| Baoen Jiang New York, NY | Internal Medicine | 1,521 | 330 | $1.1M |
| Yong S Lin New York, NY | Internal Medicine | 1,971 | 247 | $1.1M |
| Simon Li Brooklyn, NY | Family Practice | 1,324 | 173 | $963K |
| Hong Chen Brooklyn, NY | Physician Assistant | 1,019 | 180 | $938K |
| Yunkyoung Jeong Flushing, NY | Nurse Practitioner | 1,251 | 202 | $916K |
| David H Lau New York, NY | Cardiology | 1,086 | 163 | $875K |
| Chang S Lee Flushing, NY | Internal Medicine | 1,386 | 172 | $874K |
| Yun Hee Chung Flushing, NY | Internal Medicine | 898 | 167 | $759K |
| Anthony H Jung Flushing, NY | Internal Medicine | 1,033 | 153 | $738K |
| Sea H Chung Flushing, NY | Internal Medicine | 1,221 | 161 | $699K |
| Yuan Zhang New York, NY | Nurse Practitioner | 942 | 197 | $691K |
| Wingtat Mui New York, NY | Internal Medicine | 763 | 169 | $673K |
| Weining W Liang Flushing, NY | Internal Medicine | 932 | 167 | $670K |
| Yuqing Zhang Flushing, NY | Family Practice | 1,258 | 223 | $658K |
| Guozi Weng New York, NY | Nurse Practitioner | 807 | 227 | $632K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Teva USA TEVA | 125,428 | $85.9M |
| Yaral Pharma, I | 34,987 | $20.7M |
| Greenstone LLC. VTRS | 10,156 | $5.8M |